A carregar...
Liraglutide Versus Lixisenatide: Long-Term Cost-Effectiveness of GLP-1 Receptor Agonist Therapy for the Treatment of Type 2 Diabetes in Spain
INTRODUCTION: Glucagon-like peptide-1 (GLP-1) receptor agonists are used successfully in the treatment of patients with type 2 diabetes as they are associated with low hypoglycemia rates, weight loss and improved glycemic control. This study compared, in the Spanish setting, the cost-effectiveness o...
Na minha lista:
Publicado no: | Diabetes Ther |
---|---|
Main Authors: | , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Springer Healthcare
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5380501/ https://ncbi.nlm.nih.gov/pubmed/28224463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-017-0239-6 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|